HitBTC
HitBTC
HitBTC
We are a bio venture company from RIKEN, Japan (RIKEN), a major global think tank. We developed a novel cancer treatment method "RIKNKT" with minimal invasion (few overall events disturb the homeostasis in vivo due to external factors) and almost no side effect, that uses cells with intense antitumor effect researched by RIKEN and many other medical institutions. Since June 2008, we have begun offering it at private medical institutions under legal procedures in the regenerative medicine new law in Japan.
As a result of medical provision, about 80% of patients were able to obtain partial remission (A state in which the cancer contracts and the symptoms are improved), complete remission(A condition in which symptoms of cancer disappear and the numerical value of examination also shows normal), and stop progress, regardless of site or stage, which verifies that it has a high response rate (the size of cancer shrinks).
Based on these results, we will spread this therapy in full scale expecting that as many patients as possible can receive treatment from now on while cancer patients are increasing. At the same time, we will further advance our technology development. Additionally, we will continue our drug discovery business to acquire drug approval.
